Today’s top gainers include the company Grifols, S.A. (NASDAQ:GRFS) which is in the industry Biotechnology, gaining -0.50% today. In the last week its performance is -0.65%, and 9.82% for the past quarter. Currently, Grifols, S.A., GRFS has a target price of 15, so today’s gain of -0.50% is a significant step towards its target price. The GAP today is therefore 0.48%.
Grifols, S.A. (NASDAQ:GRFS), has a market cap of 23070.8, and is based in Spain. Insider ownership is at *TBA, and institutional ownership is *TBA.
At the current price of 16.75, it has a dividend yield of 3.09%, and its target price is 15. This is with a profit margin of *TBA, and total debt/equity of *TBA. Grifols, S.A. (NASDAQ:GRFS) has a P/E of 38.27, as well as a forward P/E of 14.77.
With a current EPS of 0.44, and a forecasted EPS growth for next year at 10.70%,Grifols, S.A. (NASDAQ:GRFS) has had a EPS growth for the past five years at 39.67%. For the next five years EPS growth is projected to be 15.00%.
Performance for the year is 7.23%. Since its IPO date on 6/2/2011, the total performance to date is 4.93%.
Volume today for Grifols, S.A. (NASDAQ:GRFS), is 1158256, while its average volume is 1280.4. Whilst the total gain today was -0.50%, it did have a day high of -3.71%.
Volatility for this week has been at 0.93%, and 1.66% for the month. The 52-week low for Grifols, S.A., GRFS has been 20.21%, while the 52-week-high has reached -5.20%.
Looking at its return of investments, which is *TBA, and its return on assets is *TBA. Grifols, S.A. (NASDAQ:GRFS) has an operating margin of *TBA. With a sales growth of 5.60% quarter over quarter. Bearing in mind that Grifols, S.A., GRFS is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Grifols, S.A.? Well its PEG is 2.55, and the P/S is 5.23, along with a P/B of 6.33. Meanwhile it has a p/cash of *TBA.